Deferoxamine Mesylate for Injection 2 g

Deferoxamine Mesylate for Injection 2 G is a powder for solution used to manage iron overload. This medication is administered intramuscularly and is manufactured by Pfizer Canada ULC.

Deferoxamine Mesylate is primarily used to treat conditions associated with iron overload, such as thalassemia. It works by binding to excess iron in the body, helping to remove it. This process is crucial for patients who receive frequent blood transfusions, as these can lead to high iron levels. Deferoxamine Mesylate for Injection 2 G is formulated to provide a concentrated dose for effective management.

Common effects of Deferoxamine Mesylate may include injection site reactions, such as pain or swelling. Some individuals might experience changes in vision, hearing, or gastrointestinal discomfort. These effects vary among patients and should be discussed with a healthcare provider.

Deferoxamine Mesylate should be handled with care. It is important to follow proper administration techniques to avoid injection site complications. Patients with certain medical conditions, such as kidney or liver issues, should use this medication under close supervision. Always consult a healthcare professional before starting any new medication.

Deferoxamine Mesylate may interact with other medications, including those that affect iron metabolism. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of Deferoxamine Mesylate.